| Bio Roundup: COVID-19 Pact, Gavreto Approval, Generative Biology & More | Frank Vinluan | 09/11/20 | National |
| Qpex Biopharma Launches with $33M to Tackle Drug-Resistant Infections | Frank Vinluan | 10/22/18 | San Diego |
| Biotech Roundup: Opioid News, ASH Preview, Boston Bio IPOs & More | Frank Vinluan | 11/03/17 | National |
| Spero, Allena Nab $152M As Bio IPOs, With Insider Help, Continue Roll | Ben Fidler | 11/02/17 | Boston |
| Bio Roundup: Light For Spark, California Drug Law, IPO Queue & More | Alex Lash | 10/13/17 | National |
| Celebrating Boston Life Sciences: Xconomy Awards Gala Slideshow | Corie Lok | 10/03/17 | Boston |
| The Winners of the 2017 Xconomy Awards Are… | Corie Lok | 09/26/17 | Boston |
| Dragonfly, eGenesis, Spero & More: Xconomy’s Startup Award Finalists | Corie Lok | 08/14/17 | Boston |
| Atlas Venture Unveils New $350M Fund for Seed Biotech Investments | Frank Vinluan | 06/29/17 | Boston |
| Biotech Roundup: Obamacare Lite, DePinho Out, Dunsire In & More | Ben Fidler | 03/10/17 | National |
| Google’s Venture Arm Leads $51.7M Investment in Spero Therapeutics | Frank Vinluan | 03/08/17 | Boston |
| Biotech Roundup: Duchenne Delay, Forum’s Fate, Califf, Ionis & More | Ben Fidler | 05/27/16 | National |
| Spero Rolls up More Antibiotics With Vertex Deal | Ben Fidler | 05/25/16 | Boston |
| East Coast Bio Roundup: CRISPR, Tessier-Lavigne, Pricing, Spero & More | Ben Fidler | 02/05/16 | Boston |
| Spero Eyes First Trial, Gets $30M More to Battle Drug-Resistant Bugs | Ben Fidler | 02/02/16 | Boston |
| Spero Therapeutics Receives $30,000,000 New Funding | VentureDeal | 02/02/16 | Boston |
| To Fight “Superbugs,” Roche Shells Out $190M For Bay Area’s GeneWEAVE | Ben Fidler | 08/13/15 | San Francisco |
| East Coast Biotech Roundup: XTuit, Spero, Unum, RNAi Feud & More | Ben Fidler | 06/12/15 | Boston |
| With $30M, Spero Broadens Fight Against Drug-Resistant Bugs | Ben Fidler | 06/08/15 | Boston |
| Spero Therapeutics Receives $30,000,000 Series A Funding | VentureDeal | 06/08/15 | Boston |
| Now Biotech-Only, Atlas Reloads With $280M Fund For New Startups | Ben Fidler | 04/17/15 | Boston |
| Antibiotics Startup Gets $22M From Roche, Others, For New “Macrolides” | Ben Fidler | 03/04/15 | Boston |
| Built for a Deal, Annovation Rewards Backers With Medicines Co. Buyout | Ben Fidler | 02/04/15 | Boston |
| Synlogic Gets $30M From Atlas, NEA to Turn Smart Bugs Into Drugs | Ben Fidler | 07/22/14 | Boston |
| East Coast Biotech Roundup: Agios, Spero, Cerulean, & More | Ben Fidler | 04/11/14 | Boston |
| Spero Emerges With $3M, Backing From Roche, & Plans to Disarm Bugs | Ben Fidler | 04/09/14 | Boston |
